Starting trials of the multiple sclerosis drug interferon beta to treat symptoms of corona by inhalation
The British newspaper “Daily Mail” revealed that a group trial of the reused multiple sclerosis drug had begun, which reduces the number of Corona patients suffering from serious complications by 80% in hospital. Only 13% of patients who received SNG001 treatment developed severe complications that warranted the need for intensive care, compared to 22% … Read more